[Retracted] Systemic delivery of synthetic microRNA-451 is an effective therapeutic strategy for the treatment of lung cancer
- Authors:
- Published online on: July 29, 2016 https://doi.org/10.3892/ijmm.2016.2693
- Pages: 1312-1312
-
Copyright: © Lou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article
Int J Mol Med 35: [Related article:] 1369–1373, 2015; DOI: 110.3892/ijmm.2015.2147
Following the publication of this article, an interested reader drew to our attention that Figs. 3B and 4B contained histological data which had previously been published in Figs. 3B and 4B, respectively, of the following article: Wiggins JF, Ruffino L, Kelnar K, Omotola M, Patrawala L, Brown D and Bader AG: Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res. 15: 5923–5930, 2010.
We have tried to contact the authors of the above paper on several occasions for comment, but without success; therefore, the Editorial Board of the International Journal of Molecular Medicine has taken the decision to retract this publication. We thank the reader for drawing this matter to our attention.
